© biotech Capital 2017
Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for
listed biotech companies to interact with
institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's
leading analysts and journalists, publishing daily content, covering all key movements
in the Biotechnology market.